Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ · Healthcare
Zentalis Pharmaceuticals, Inc. Total Liabilities 2022–2025
Zentalis Pharmaceuticals, Inc. annual/quarterly total liabilities history from 2022 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Zentalis Pharmaceuticals, Inc. total liabilities for the quarter ending December 31, 2025 were 72.8M, a 21.89% decrease year-over-year.
- Zentalis Pharmaceuticals, Inc. total liabilities for 2025 were 72.8M, a 21.89% decrease from 2024.
- Zentalis Pharmaceuticals, Inc. total liabilities for 2024 were 93.2M, a 18.50% decrease from 2023.
- Zentalis Pharmaceuticals, Inc. total liabilities for 2023 were 114.3M, a 8.56% increase from 2022.
- Zentalis Pharmaceuticals, Inc. total liabilities for 2022 were 105.3M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Zentalis Pharmaceuticals, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $73 |
| 2024 | $93 |
| 2023 | $114 |
| 2022 | $105 |
| Zentalis Pharmaceuticals, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $73 |
| 2024-12-31 | $93 |
| 2023-12-31 | $114 |
| 2022-12-31 | $105 |
Zentalis Pharmaceuticals, Inc. Total Liabilities — FAQ
Zentalis Pharmaceuticals, Inc. (ZNTL) total liabilities over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ZNTL's total liabilities history?
The chart and table above show Zentalis Pharmaceuticals, Inc.'s total liabilities by year and by quarter, including the growth rate.